Centrally acting ACE inhibitor (cACEi) and angiotensin receptor blocker (cARB) use and cognitive dysfunction in patients with SLE.

Chrisanna Dobrowolski,Michelle Barraclough,Jiandong Su,Milica Tanic,Kathleen Bingham,Lesley Ruttan,Dorcas Beaton,Joan Wither,Maria Carmela Tartaglia,Mary Sano,Mahta Kakvan,Dennisse Bonilla,Robin Green,Zahi Touma

Lupus science & medicine（2023）

引用 0|浏览5

暂无评分

摘要

In a single-centre SLE cohort, cACEi/cARB use was not associated with absence of CD. Many important confounders may have influenced the results of this retrospective study. A randomised trial is required to accurately determine if cACEi/cARB is a potential treatment for SLE-CD.

查看译文

关键词

Lupus Erythematosus, Systemic, Epidemiology, Autoimmunity, Outcome Assessment, Health Care, Anti-Inflammatory Agents, Non-Steroidal

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要